These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29067158)

  • 1. Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis.
    Paulon E; Nastou D; Jaboli F; Marin J; Liebler E; Epstein O
    Frontline Gastroenterol; 2017 Oct; 8(4):325-330. PubMed ID: 29067158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis.
    Gottfried-Blackmore A; Adler EP; Fernandez-Becker N; Clarke J; Habtezion A; Nguyen L
    Neurogastroenterol Motil; 2020 Apr; 32(4):e13769. PubMed ID: 31802596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
    Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
    Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
    Heckert J; Parkman HP
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
    Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
    Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study.
    Kinfe TM; Pintea B; Muhammad S; Zaremba S; Roeske S; Simon BJ; Vatter H
    J Headache Pain; 2015; 16():101. PubMed ID: 26631234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.
    Li JL; Li M; Pang B; Zhou Q; Tian JX; Liu HX; Zhao XY; Tong XL
    World J Gastroenterol; 2014 Jul; 20(26):8674-80. PubMed ID: 25024625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and content validity of a gastroparesis cardinal symptom index daily diary.
    Revicki DA; Camilleri M; Kuo B; Norton NJ; Murray L; Palsgrove A; Parkman HP
    Aliment Pharmacol Ther; 2009 Sep; 30(6):670-80. PubMed ID: 19558608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy.
    Cassilly DW; Wang YR; Friedenberg FK; Nelson DB; Maurer AH; Parkman HP
    Digestion; 2008; 78(2-3):144-51. PubMed ID: 19033686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcome of Gastric Per-Oral Endoscopic Pyloromyotomy in Treatment of Gastroparesis.
    Abdelfatah MM; Noll A; Kapil N; Shah R; Li L; Nustas R; Li B; Luo H; Chen H; Xia L; Mekaroonkamol P; Shahnavaz N; Keilin S; Willingham F; Christie J; Cai Q
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):816-824. PubMed ID: 32450364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
    Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
    Aliment Pharmacol Ther; 2003 Jul; 18(1):141-50. PubMed ID: 12848636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis.
    Revicki DA; Speck RM; Lavoie S; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13553. PubMed ID: 30734412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis.
    Revicki DA; Lavoie S; Speck RM; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
    J Patient Rep Outcomes; 2018 Dec; 2(1):61. PubMed ID: 30547386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).
    Parkman HP; Yates KP; Sarosiek I; Bulat RS; Abell TL; Koch KL; Kuo B; Grover M; Farrugia G; Silver P; Abdullah A; Maurer AH; Malik Z; Miriel LA; Tonascia J; Hamilton F; Pasricha PJ; McCallum RW;
    Aliment Pharmacol Ther; 2023 Jun; 57(11):1272-1289. PubMed ID: 37052334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric Peroral Endoscopic Myotomy (G-POEM) as a Treatment for Refractory Gastroparesis: Long-Term Outcomes.
    Xu J; Chen T; Elkholy S; Xu M; Zhong Y; Zhang Y; Chen W; Qin W; Cai M; Zhou P
    Can J Gastroenterol Hepatol; 2018; 2018():6409698. PubMed ID: 30425974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.
    Lacy BE; Everhart K; Crowell MD
    Dig Dis Sci; 2019 May; 64(5):1281-1287. PubMed ID: 30382539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.
    Midani D; Parkman HP
    J Neurogastroenterol Motil; 2016 Oct; 22(4):650-655. PubMed ID: 27400689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video).
    Gonzalez JM; Lestelle V; Benezech A; Cohen J; Vitton V; Grimaud JC; Barthet M
    Gastrointest Endosc; 2017 Jan; 85(1):132-139. PubMed ID: 27478028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Feasibility of Per-Oral Pyloromyotomy as Augmentative Therapy after Prior Gastric Electrical Stimulation for Gastroparesis.
    Strong AT; Rodriguez J; Kroh M; Ponsky J; Cline M; El-Hayek K
    J Am Coll Surg; 2019 Dec; 229(6):589-595. PubMed ID: 31610231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
    Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
    Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.